Let’s start with a look at your coverage, and how it might have changed since we spoke in 2023. Mr. Lichtman: Sure. I cover a large group of medical device companies from micro cap to mega cap. I ...

Today it was announced that pharmaceuticals are not exempt from Trump’s tariffs. How does this apply to medical devices? Are most devices manufactured offshore? Mr. Wittes: It’s company by company, ...

Let’s start with an overview of the company and some notable milestones. Mr. Levy: Sure. You know, a major challenge for cancer patients and their caregivers today is that while we’ve seen incredible ...

Please tell us about Puma Biotechnology. Mr. Auerbach: I’d be more than happy to. Puma is a biotech company that is dedicated to the development and commercialization of drugs for the treatment of ...

How is your coverage weathering the tariff storm? Dr. Brozak: Our life sciences dedicated franchise, WBB Securities, is the busiest we’ve ever been in the history of the firm, and the life sciences ...

Please give us an overview of BioHarvest and its products and services. Mr. Sobel: I have the privilege of being CEO of BioHarvest Sciences. BioHarvest Sciences is the global leader in plant cell ...

We’ve spoken before, but just for readers who may not be familiar, let’s start with a refresher on the company, its mission, and some milestones. Mr. Do: BioVie has two assets that we are currently ...

We’ve spoken before, but as a refresher for our readers, can you talk a little bit about the company, including some major milestones? Mr. de Garidel: So, Abivax is a company that is primarily ...

Bear market investing protection from Jeremy A. Ellis of Campbell Newman Asset Management and Jeffrey Lent, Torray Investment ...

Austin R. Kummer, CFA, is Managing Director and Senior Portfolio Manager for Multi-Sector Fixed Income, Multi-Strategy, and Dividend Equity strategies at Fort Washington Investment Advisors, Inc ...

Jeremy A. Ellis, CFA, is a Portfolio Manager/Analyst at Campbell Newman Asset Management, Inc. He began his career in the investment management industry in 2007. Mr. Ellis joined Campbell Newman ...